A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 Plus Standard of Care (SOC) Versus Placebo Plus Standard of Care in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (E-CELERATE) (NCT05181540) - Trials in Progress

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.10573-10574
Main Authors: Scordo, Michael, Shouse, Geoffrey, Mountjoy, Luke, Gauthier, Jordan, Dholaria, Bhagirathbhai, Rowley, Scott D., Pantin, Jeremy M., Defilipp, Zachariah, Mead, Monica, Finnegan, Paul
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-162373